Open AccessA Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates
Author(s) -
Jian He,
Mei Meng,
Hui Wang
Publication year - 2021
Publication title -
journal of clinical and translational hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.042
H-Index - 29
eISSN - 2310-8819
pISSN - 2225-0719
DOI - 10.14218/jcth.2021.00047
Subject(s) - immune system , medicine , hepatocellular carcinoma , cancer research , liver cancer , metastasis , cd8 , biomarker , cancer cell , cancer , oncology , immunology , biology , biochemistry
LPAR6 is the most recently determined G protein-coupled receptor of lysophosphatidic acid, and hardly any study has demonstrated the performance of LPAR6 in cancers. We sought to clarify the relationship of LPAR6 to prognosis potential and tumor infiltration immune cells in different cancers.